DR. MICHAEL EDWARD MURPHY MD
Prescription History 1164580973
Dermatology - MOHS-Micrographic Surgery in Greenwood, IN


Quality Rating: 100 out of 100 score

NPI Status: Active since December 05, 2006

Contact Information

701 E. COUNTY LINE ROAD
SUITE 208
GREENWOOD, IN
ZIP 46143
Phone: (317) 859-8970
Fax: (317) 859-8977

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. MICHAEL EDWARD MURPHY MD, an active MOHS-Micrographic Surgery specialist practicing in Greenwood, IN. Our medical registry currently tracks 17 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,026 documented patient claims. Among these therapy options, the most frequently utilized medication is Cephalexin, which accounts for 257 claims alone.


Acetaminophen-Codeine

Generic Formulation: Acetaminophen With CodeineSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 19
30-Day Fills 19.0
Days Supply 56
IN State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills26.0
Peer Average Days Supply411
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $51.40 across this reporting matrix range.

Provider Avg Cost Per Claim

$2.71

State Avg Cost Per Claim

$15.26

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

See also Warning section. This combination medication is used to help relieve mild to moderate pain. It contains an opioid pain reliever (codeine) and a non-opioid pain reliever (acetaminophen). Codeine works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Amoxicillin

Generic Formulation: AmoxicillinSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 86
30-Day Fills 86.0
Days Supply 125
IN State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills39.0
Peer Average Days Supply264
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 126.3% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $91.01 across this reporting matrix range.

Provider Avg Cost Per Claim

$1.06

State Avg Cost Per Claim

$3.76

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration.

Therapeutic Applications

Amoxicillin is used to treat a wide variety of bacterial infections. This medication is a penicillin-type antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Amoxicillin is also used with other medications to treat stomach/intestinal ulcers caused by the bacteria H. pylori and to prevent the ulcers from returning.

Cephalexin

Generic Formulation: CephalexinSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 257
30-Day Fills 257.0
Days Supply 1,779
IN State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills36.4
Peer Average Days Supply393
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 678.8% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,675.15 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.52

State Avg Cost Per Claim

$8.94

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.

Therapeutic Applications

This medication is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Ciprofloxacin Hcl

Generic Formulation: Ciprofloxacin HclSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 53
30-Day Fills 53.0
Days Supply 390
IN State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills29.4
Peer Average Days Supply259
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 89.3% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $330.84 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.24

State Avg Cost Per Claim

$8.32

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A broad-spectrum antimicrobial carboxyfluoroquinoline.

Therapeutic Applications

This medication is used to treat eye infections. Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

Clindamycin Hcl

Generic Formulation: Clindamycin HclSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 19
30-Day Fills 19.0
Days Supply 32
IN State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills22.2
Peer Average Days Supply157
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $26.89 across this reporting matrix range.

Provider Avg Cost Per Claim

$1.42

State Avg Cost Per Claim

$9.41

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An antibacterial agent that is a semisynthetic analog of LINCOMYCIN.

Therapeutic Applications

Clindamycin is used to treat a wide variety of bacterial infections. It is an antibiotic that works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Clindamycin Phosphate

Generic Formulation: Clindamycin PhosphateSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 18
30-Day Fills 23.0
Days Supply 690
IN State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills28.5
Peer Average Days Supply797
Conservative Utilization

This provider writes prescriptions for this formulation 28.0% less frequently than the standard regional baseline metric for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $789.57 across this reporting matrix range.

Provider Avg Cost Per Claim

$43.87

State Avg Cost Per Claim

$55.22

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat a certain type of vaginal infection (bacterial vaginosis) in women who are not pregnant. Clindamycin is an antibiotic which works by stopping the growth of bacteria.

Clobetasol Propionate

Generic Formulation: Clobetasol PropionateSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 58
30-Day Fills 62.0
Days Supply 1,373
IN State Average Benchmarks
Peer Average Claims39.0
Peer Average 30-Day Fills42.7
Peer Average Days Supply1,088
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 48.7% more claims than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,979.15 across this reporting matrix range.

Provider Avg Cost Per Claim

$51.36

State Avg Cost Per Claim

$68.67

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A derivative of PREDNISOLONE with high glucocorticoid activity and low mineralocorticoid activity. Absorbed through the skin faster than FLUOCINONIDE, it is used topically in treatment of PSORIASIS but may cause marked adrenocortical suppression.

Therapeutic Applications

This medication is used to treat a variety of skin conditions (such as eczema, psoriasis, dermatitis, allergies, rash). Clobetasol reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a very strong (super-high-potency) corticosteroid.

Doxycycline Hyclate

Generic Formulation: Doxycycline HyclateSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 28
30-Day Fills 34.4
Days Supply 826
IN State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills32.2
Peer Average Days Supply431
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $881.35 across this reporting matrix range.

Provider Avg Cost Per Claim

$31.48

State Avg Cost Per Claim

$23.61

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic tetracycline derivative with similar antimicrobial activity.

Therapeutic Applications

This medication is used to treat a wide variety of bacterial infections, including those that cause acne. This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Fluocinonide

Generic Formulation: FluocinonideSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 33
30-Day Fills 34.0
Days Supply 969
IN State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills32.3
Peer Average Days Supply853
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,381.83 across this reporting matrix range.

Provider Avg Cost Per Claim

$41.87

State Avg Cost Per Claim

$60.77

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A topical glucocorticoid used in the treatment of ECZEMA.

Therapeutic Applications

This medication is used to treat a variety of skin conditions (such as eczema, dermatitis, psoriasis, allergies, rash). Fluocinonide reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a strong corticosteroid.

Fluorouracil

Generic Formulation: FluorouracilSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 85
30-Day Fills 86.4
Days Supply 2,052
IN State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills38.5
Peer Average Days Supply984
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 136.1% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,625.26 across this reporting matrix range.

Provider Avg Cost Per Claim

$101.47

State Avg Cost Per Claim

$111.39

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.

Therapeutic Applications

Fluorouracil is used to treat various types of cancer. It is a chemotherapy drug that is used to slow or stop cancer cell growth.

Imiquimod

Generic Formulation: ImiquimodSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 49
30-Day Fills 49.0
Days Supply 1,048
IN State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills36.7
Peer Average Days Supply951
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 53.1% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,467.42 across this reporting matrix range.

Provider Avg Cost Per Claim

$29.95

State Avg Cost Per Claim

$43.82

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A topically-applied aminoquinoline immune modulator that induces interferon production. It is used in the treatment of external genital and perianal warts, superficial CARCINOMA, BASAL CELL; and ACTINIC KERATOSIS.

Therapeutic Applications

This medication is used to treat certain types of growths on the skin. These are precancerous growths (actinic keratoses), a certain type of skin cancer (superficial basal cell carcinoma), and warts on the outside of the genitals/anus. Treating these conditions can decrease complications from them. Imiquimod belongs to a group of drugs called immune response modifiers. It is believed to work by helping to activate your immune system to fight these abnormal skin growths. This product is not recommended for use on children under 12 years of age unless specifically directed by your doctor.

Ketoconazole

Generic Formulation: KetoconazoleSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 22
30-Day Fills 28.0
Days Supply 794
IN State Average Benchmarks
Peer Average Claims46.0
Peer Average 30-Day Fills50.9
Peer Average Days Supply1,353
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 52.2% less volume than the regional standard for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $935.44 across this reporting matrix range.

Provider Avg Cost Per Claim

$42.52

State Avg Cost Per Claim

$25.88

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients.

Therapeutic Applications

This medication is used to control dandruff. Use of this medication may help to relieve the flaking, scaling and itching associated with dandruff. Ketoconazole is an azole antifungal that works by preventing the growth of fungus. Ketoconazole 2% shampoo is also used to treat a skin condition known as pityriasis (tinea versicolor), a fungal infection that causes a lightening or darkening of the skin of the neck, chest, arms, or legs.

Metronidazole

Generic Formulation: MetronidazoleSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 12
30-Day Fills 13.0
Days Supply 335
IN State Average Benchmarks
Peer Average Claims11.0
Peer Average 30-Day Fills11.0
Peer Average Days Supply35
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $676.60 across this reporting matrix range.

Provider Avg Cost Per Claim

$56.38

State Avg Cost Per Claim

$19.13

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.

Therapeutic Applications

This medication is used on the skin to treat a certain skin disorder known as rosacea, a type of adult acne. It may help to decrease redness, swelling and the number of pimples caused by rosacea. This medication is an antibiotic. For the treatment of rosacea, metronidazole is believed to work by decreasing swelling (inflammation). Some brands of this medication also contain sunscreens (see also Notes section).

Mupirocin

Generic Formulation: MupirocinSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 62
30-Day Fills 63.0
Days Supply 1,316
IN State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills30.1
Peer Average Days Supply453
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 113.8% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,048.08 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.90

State Avg Cost Per Claim

$12.23

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.

Therapeutic Applications

Mupirocin is used to treat certain skin infections (such as impetigo). It is an antibiotic. It works by stopping the growth of certain bacteria.

Sulfamethoxazole-Trimethoprim

Generic Formulation: Sulfamethoxazole/TrimethoprimSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 39
30-Day Fills 39.0
Days Supply 279
IN State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills30.6
Peer Average Days Supply407
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 44.4% more claims than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $187.07 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.80

State Avg Cost Per Claim

$6.14

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.

Therapeutic Applications

This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Tramadol Hcl

Generic Formulation: Tramadol HclSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 29
30-Day Fills 29.0
Days Supply 111
IN State Average Benchmarks
Peer Average Claims59.0
Peer Average 30-Day Fills60.1
Peer Average Days Supply1,211
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 50.8% less volume than the regional standard for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $62.31 across this reporting matrix range.

Provider Avg Cost Per Claim

$2.15

State Avg Cost Per Claim

$7.94

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A narcotic analgesic proposed for severe pain. It may be habituating.

Therapeutic Applications

See also Warning section. This medication is used to help relieve moderate to moderately severe pain. Tramadol belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Triamcinolone Acetonide

Generic Formulation: Triamcinolone AcetonideSpecialty: Micrographic Dermatologic Surgery
Provider Metrics Summary
Total Claims 157
30-Day Fills 166.5
Days Supply 3,812
IN State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills39.7
Peer Average Days Supply943
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 348.6% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,432.71 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.13

State Avg Cost Per Claim

$11.15

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions.

Therapeutic Applications

This medication is used in a variety of conditions such as allergic disorders, arthritis, gout, blood diseases, breathing problems, certain cancers, eye diseases, intestinal disorders, collagen and skin diseases. Talk to your doctor about the risks and benefits of triamcinolone, especially if it is to be injected near your spine (epidural). Rare but serious side effects may occur with epidural use. Triamcinolone is known as a corticosteroid hormone (glucocorticoid). It works by decreasing your body's immune response to these diseases and reduces symptoms such as swelling.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. MICHAEL EDWARD MURPHY MD provides transparency into local medical care patterns within Greenwood, IN.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **MOHS-Micrographic Surgery** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.